Search research articles
Contact Us
Filters
Showing results (121-130 of 124) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 124 results.
Med (New York, N.Y.)
|
October 7, 2021
Invariant Natural Killer T cells coordinate removal of senescent cells
Shivani Arora, Peter J Thompson, Yao Wang, et al.
BMJ Open Quality
|
August 21, 2019
Stratification of inflammatory bowel disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project
Rishi K Fofaria, Susan Barber, Yewande Adeleke, et al.
Science and Technology of Advanced Materials
|
November 24, 2016
Electrical isolation of dislocations in Ge layers on Si(001) substrates through CMOS-compatible suspended structures
Vishal Ajit Shah, Maksym Myronov, Chalermwat Wongwanitwatana, et al.
Investigational New Drugs
|
July 14, 2007
A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors
Jérôme Alexandre, Carmen Kahatt, Frédérique Bertheault-Cvitkovic, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 124) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 124 results.
Med (New York, N.Y.)
|
October 7, 2021
Invariant Natural Killer T cells coordinate removal of senescent cells
Shivani Arora, Peter J Thompson, Yao Wang, et al.
BMJ Open Quality
|
August 21, 2019
Stratification of inflammatory bowel disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project
Rishi K Fofaria, Susan Barber, Yewande Adeleke, et al.
Science and Technology of Advanced Materials
|
November 24, 2016
Electrical isolation of dislocations in Ge layers on Si(001) substrates through CMOS-compatible suspended structures
Vishal Ajit Shah, Maksym Myronov, Chalermwat Wongwanitwatana, et al.
Investigational New Drugs
|
July 14, 2007
A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors
Jérôme Alexandre, Carmen Kahatt, Frédérique Bertheault-Cvitkovic, et al.
Page
of 13